CRIS (Curis Corp) Kacepetan wutah bathi saben saham ing taun lumaku
The annual net income per share trend for Curis, Inc. (CRIS) on GURU.Markets reflects the asset's volatility, with the latest reading at -30.40. Curis, Inc. (CRIS) management is focusing on the regulation of cellular pathways and partnerships with industry behemoths. Revenues are based on the commercialization of targeted therapies for leukemia and lymphomas. The absence of approved products eliminates inertial cash flow, leaving the budget dependent on equity issuances and external tranches.
Rincian metrik keuangan lan pasar Curis, Inc. (CRIS)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Curis, Inc.|CRIS - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Curis Corp|CRIS - Utang perusahaan|Utang-utang marang aset resik Curis Inc.|CRIS - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Curis|Koefisien jangkoan perantara curis.com
- data bathi resik lan rasio valuasi:
CRIS - Bathi resik perusahaan|Prakiraan bathi resik Curis, Inc.|CRIS - Pangali P/E|Prakiraan rega marang bathi Curis, Inc.|CRIS - Pangali rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Curis|CRIS - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Curis|CRIS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan curis.com|CRIS - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Curis, Inc.
- statistik dodolan lan pendapatan perusahaan:
Analisis dhasar perusahaan:CRIS - Curis
This indicator is calculated as the percentage deviation of current earnings per share from the value of the same period last year. The metric determines the growth rate of capital efficiency and the business's resilience to operational shocks. For Curis, Inc., which invests in oncology development and partnerships with pharma behemoths, this serves as a marker of the financial viability of the R&D cycle. By analyzing the volatility of annual earnings per share, an investor distinguishes real growth from speculation.
Pesaing wigati
Kacepetan wutah bathi saben saham ing taun lumaku BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku revmed.com RVMD|Wutah bathi ing taun lumaku AAPG|Wutah bathi resik saben saham ing taun iki CG Oncology CGON|Wutah bathi saben saham ing taun lumaku UroGen URGN|Prakiraan wutah bathi resik saben saham ing taun iki Bicara Bio (BCAX)|PSNL - Wutah bathi saben saham ing taun lumaku|ERAS - Wutah bathi ing taun lumaku|DCTH: Wutah bathi ing taun lumaku|Y-mAbs Therapeutics, Inc. (YMAB) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki AURA|Kacepetan wutah bathi saben saham ing taun lumaku candeltx.com CADL|Wutah bathi ing taun lumaku ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ACTU (Actuate Therapeutics Inc)|Tambahing bathi saben saham ing taun lumaku CTOR|tuhurabio.com - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Wutah bathi saben saham ing taun lumaku|WHWK - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku tscan.com|CSBR: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku XBiotech USA (XBIT)|CVM: Dinamika bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku ostherapies.com OSTX|Wutah bathi resik saben siji saham kanggo taun lumaku RADX (Radiopharm Theranostics Limited)|Artiva - Wutah bathi ing taun lumaku|ANL: Wutah bathi saben saham ing taun lumaku|VERU: Wutah bathi ing taun lumaku|Dinamika bathi saben saham ing taun lumaku TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku renovarobio.com RENB|Wutah bathi saben saham ing taun lumaku muraloncology.com (MURA)|Wutah bathi resik saben siji saham kanggo taun lumaku KAPA|Wutah bathi ing taun lumaku OKUR (onkuretherapeutics.com)|Wutah bathi resik saben siji saham kanggo taun lumaku GDTC (CytoMed)|APLM - Wutah bathi saben saham ing taun lumaku|THAR - Wutah bathi ing taun lumaku|ADVB: Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku SBFM|Wutah bathi ing taun lumaku XBIO|Wutah bathi resik saben saham ing taun iki Salarius Pharmaceuticals SLRX|Wutah bathi ing taun lumaku PPBT (Purple Biotech Ltd)|AONC - Wutah bathi resik saben saham ing taun iki|BGNE: Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham ing taun iki Checkpoint Therapeutics, Inc CKPT|ELEV: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku iCAD Inc. (ICAD)|IKNA (Ikena) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Notable Labs (NTBL)|Wutah bathi ing taun lumaku VIRX|Wutah bathi resik saben saham ing taun iki MorphoSys Corporation MOR|NAYA Biosciences - Wutah bathi resik saben saham ing taun iki|Owah-owahan bathi resik saben saham ing taun lumaku Ascentage Pharma
